Patents by Inventor Ritesh V. Thekkedath

Ritesh V. Thekkedath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
    Patent number: 11814408
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic gent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, Meibomian gland dysfuntion or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: November 14, 2023
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Thomas Cavanagh, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20210300963
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic gent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, Meibomian gland dysfuntion or skin inflammatiom or a respiratory disease (e.g., asthma).
    Type: Application
    Filed: February 17, 2021
    Publication date: September 30, 2021
    Inventors: Thomas CAVANAGH, Shikha P. BARMAN, Tian HAO, Thomas B. LELAND, Ritesh V. THEKKEDATH
  • Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
    Patent number: 10954263
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: March 23, 2021
    Assignee: NICOX OPHTHALMICS, INC
    Inventors: Thomas Cavanagh, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • Membrane-adherent self-assembled systems for treatment of ocular disorders
    Patent number: 10603273
    Abstract: A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug delivery system and methods for treating ocular disorders by administering it to a subject.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: March 31, 2020
    Assignee: Integral Biosystems LLC
    Inventors: Shikha P. Barman, Kevin L. Ward, Anne-Marie Cromwick, Koushik Barman, Ritesh V. Thekkedath
  • PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20190169224
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Application
    Filed: November 28, 2018
    Publication date: June 6, 2019
    Inventors: Thomas CAVANAGH, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
    Patent number: 10174071
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: January 8, 2019
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Thomas Cavanagh, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • MEMBRANE-ADHERENT SELF-ASSEMBLED SYSTEMS FOR TREATMENT OF OCULAR DISORDERS
    Publication number: 20180185275
    Abstract: A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug delivery system and methods for treating ocular disorders by administering it to a subject.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Shikha P. Barman, Kevin L. Ward, Anne-Marie Cromwick, Koushik Barman, Ritesh V. Thekkedath
  • Membrane-adherent self-assembled system for treatment of ocular disorders
    Patent number: 9901544
    Abstract: A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug delivery system and methods for treating ocular disorders by administering it to a subject.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: February 27, 2018
    Assignee: Integral Biosystems LLC
    Inventors: Shikha P Barman, Kevin L. Ward, Anne-Marie Cromwick, Koushik Barman, Ritesh V. Thekkedath
  • PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20180022775
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Application
    Filed: July 26, 2017
    Publication date: January 25, 2018
    Inventors: Thomas CAVANAGH, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
    Patent number: 9822142
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: November 21, 2017
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Thomas Cavanagh, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath
  • MEMBRANE-ADHERENT SELF-ASSEMBLED SYSTEMS FOR TREATMENT OF OCULAR DISORDERS
    Publication number: 20170049697
    Abstract: A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug delivery system and methods for treating ocular disorders by administering it to a subject.
    Type: Application
    Filed: May 1, 2015
    Publication date: February 23, 2017
    Inventors: Shikha P Barman, Kevin L. Ward, Anne-Marie Cromwick, Koushik Barman, Ritesh V. Thekkedath
  • PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20150126483
    Abstract: The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).
    Type: Application
    Filed: May 6, 2013
    Publication date: May 7, 2015
    Inventors: Thomas Cavanagh, Shikha P. Barman, Tian Hao, Thomas B. Leland, Ritesh V. Thekkedath